Skip to content

Clinical trial of two Ayurvedic formulations on asthma (Shwasa Roga) patients

An open level clinical trial of two Ayurvedic formulations on asthma (Shwasa Roga) patients - CTAFAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032713
Enrollment
10
Registered
2021-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: Vasavaleha: Vasa (Adhatoda vasica) leaves juice will be prepared from freshly collected A. vasica leaves. Sugar candy will be added to it, and boiling will be done until obtaining of th

Sponsors

J B Roy State Ayurvedic Medical College and Hospital
Lead Sponsor
Indian Institute of Chemical Biology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient has a diagnosis of asthma and a current prescription for an asthma drug. 2. Careful history will be taken of isolated wheeze, wheeze with dyspnoea, exercise dyspnoea, wheezing in absence of cold, nocturnal chest tightness, nocturnal cough, nocturnal dyspnoea, chronic phlegm production and chronic cough.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from dyspnoea resulting from other diseases such as left ventricular failure, chronic obstructive pulmonary disease (chronic bronchitis, emphysema), upper respiratory tract obstruction, pneumonia, tuberculosis, lung cancer, lung abscess, and other such complicated conditions, immuno deficiency disease (AIDS) and pregnant lady.

Design outcomes

Primary

MeasureTime frame
Efficacy of the Vasavaleha will be determined by specific grading pattern including asthma control questionnaire (ACQ) and asthma control test (ACT) in terms of relief observed in cardinal signs and symptoms before and after treatment. Changes in FEV1, PEFR, BHT, and AEC will also be considered in evaluating efficacy of the test drug.Timepoint: 1.5 years for patients enrollment.

Secondary

MeasureTime frame
To observe efficacy of Vasavaleha on steroid resistant bronchial asthmaTimepoint: 1.5 years.

Countries

India

Contacts

Public ContactDr Prasanta Kumar Sarkar

J. B. Roy State Ayurvedic Medical College and Hospital

prasantaksarkar@yahoo.com9836662816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026